Moderna CEO Letter Says With A Full Season Of RSV Contracting In 2025, Expect To Increase MRESVIA's Market Share In U.S. And Market Access Globally; Plan To Bring Manufacturing Plants Online In The UK, Canada And Australia In 2025
Moderna CEO Letter Says With A Full Season Of RSV Contracting In 2025, Expect To Increase MRESVIA's Market Share In U.S. And Market Access Globally; Plan To Bring Manufacturing Plants Online In The UK, Canada And Australia In 2025
Moderna首席執行官信中表示,隨着2025年RSV感染的完整季節,預計將在美國增加MRESVIA的市場份額並在全球實現市場準入;計劃在2025年在英國、加拿大和澳洲上線製造工廠。
Moderna CEO Letter Says With A Full Season Of RSV Contracting In 2025, Expect To Increase MRESVIA's Market Share In U.S. And Market Access Globally; Plan To Bring Manufacturing Plants Online In The UK, Canada And Australia In 2025
Moderna首席執行官的信函表示,預計在2025年RSV感染的完整季節中,將提高MRESVIA在美國的市場份額和全球市場準入;計劃在2025年在英國、加拿大和澳洲上線製造廠。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。